Odevixibat
Odevixibat (A4250) is a potent, selective, and orally administered inhibitor of the ileal bile acid transporter (IBAT) . It is a research tool for investigating cholestatic liver diseases, such as primary biliary cholangitis, and has demonstrated efficacy in reducing liver and bile duct injury in murine models.
Product Specifications
CAS Number
501692-44-0
Product Name Alternative
A4250, A-4250, A 4250, IBAT, Odevixibat
Field of Research
Pharmacology & Drug Discovery
Purity
99.53% (May vary between batches)
Solubility
DMSO:150 mg/mL (202.45 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (6.75 mM)
Smiles
CCCCC1 (CCCC) CN (c2ccccc2) c2cc (SC) c (OCC (=O) N[C@@H] (C (=O) N[C@@H] (CC) C (O) =O) c3ccc (O) cc3) cc2S (=O) (=O) N1
Molecular Formula
C37H48N4O8S2
Molecular Weight
740.93
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
DZ41673-Fluoro550 200 µL/Vial
Anti-Mus musculus papillomavirus type 1mE1^E4 Antibody Fluoro550 Conjugated
Sign In for Pricing
View Details 
I7663-31Q2-APC 100 µL
Interleukin 2 Receptor, alpha (IL-2Ra, IL-2R alpha, CD25, IDDM10, Ly43, p55, T Cell Growth Factor Receptor, TCGFR, TAC Antigen) (APC) discontinued
Sign In for Pricing
View Details 040894-ML550 100 µL
RBM39, NT (RBM39, HCC1, RNPC2, RNA-binding protein 39, Hepatocellular carcinoma protein 1, RNA-binding motif protein 39, RNA-binding region-containing protein 2, Splicing factor HCC1) (MaxLight 550) discontinued
Sign In for Pricing
View Details